Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 25;14(1):12.
doi: 10.1186/s13044-021-00102-4.

The interrelationship between pregnancy, venous thromboembolism, and thyroid disease: a hypothesis-generating review

Affiliations
Review

The interrelationship between pregnancy, venous thromboembolism, and thyroid disease: a hypothesis-generating review

Stine Linding Andersen et al. Thyroid Res. .

Abstract

Pregnancy induces physiological changes that affect the risk of thrombosis and thyroid disease. In this hypothesis-generating review, the physiological changes in the coagulation system and in thyroid function during a normal pregnancy are described, and the incidence of venous thromboembolism (VTE) and thyroid disease in and after a pregnancy are compared and discussed. Furthermore, evidence regarding the association between thyroid disease and VTE in non-pregnant individuals is scrutinized. In conclusion, a normal pregnancy entails hormonal changes, which influence the onset of VTE and thyroid disease. Current evidence suggests an association between thyroid disease and VTE in non-pregnant individuals. This review proposes the hypothesis that maternal thyroid disease associates with VTE in pregnant women and call for future research studies on this subject. If an association exists in pregnant women specifically, such findings may have clinical implications regarding strategies for thyroid function testing and potential thromboprophylaxis in selected individuals.

Keywords: Coagulation; Postpartum; Pregnancy; Thrombosis; Thyroid.

PubMed Disclaimer

Conflict of interest statement

The author declares that she has no competing interests.

Figures

Fig. 1
Fig. 1
A simplified overview of the secondary hemostasis including the main alterations in pregnancy. Factors that considerably change in pregnancy are marked in bold (protein S (PS) decreases, others increase), and anticoagulants are marked in italic. See text for details. AT; antithrombin, PAI-1; plasminogen activator inhibitor-1, PAI-2: plasminogen activator inhibitor-2, PCa; activated protein C, TF: tissue factor, TFPI; tissue factor pathway inhibitor, t-PA; tissue-type plasminogen activator
Fig. 2
Fig. 2
Illustration of the incidence rates of venous thromboembolism, hyperthyroidism, and hypothyroidism in and around pregnancy. The illustration is made using data from Danish nationwide investigations [1, 6, 7]
Fig. 3
Fig. 3
Illustration of the upper (97.5 percentile) and lower (2.5 percentile) reference limit with 95% confidence interval for maternal thyroid stimulating hormone (TSH) in early pregnancy stratified by weeks of pregnancy. Data are from a regional Danish investigation in which maternal TSH was assessed using different biochemical methods (filled circles: Cobas 8000, Roche Diagnostics, open circles: ADVIA Centaur XPT, Siemens Healthineers) [34]

References

    1. Virkus RA, Leth Løkkegaard EC, Bergholt T, Mogensen U, Langhoff-Roos J, Lidegaard Ø. Venous thromboembolism in pregnant and puerperal women in Denmark 1995-2005; a national cohort study. Thromb Haemost. 2011;106(2):304–309. doi: 10.1160/TH10-12-0823. - DOI - PubMed
    1. Parunov LA, Soshitova NP, Ovanesov MV, Panteleev MA, Serebriyskiy II. Epidemiology of venous thromboembolism (VTE) associated with pregnancy. Birth Defects Res C Embryo Today. 2015;105(3):167–184. doi: 10.1002/bdrc.21105. - DOI - PubMed
    1. Kourlaba G, Relakis J, Kontodimas S, Holm MV, Maniadakis N. A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women. Int J Gynaecol Obstet Off organ Int Fed Gynaecol Obstet. 2016;132(1):4–10. doi: 10.1016/j.ijgo.2015.06.054. - DOI - PubMed
    1. Laurberg P, Andersen SL. Endocrinology in pregnancy: Pregnancy and the incidence, diagnosing and therapy of graves’ disease. Eur J Endocrinol. 2016;175(5):R219–R230. doi: 10.1530/EJE-16-0410. - DOI - PubMed
    1. Weetman AP. Immunity, thyroid function and pregnancy: molecular mechanisms. Nat Rev. 2010;6:311–318. - PubMed

LinkOut - more resources